Pentadecanoic Acid for Healthy Aging
What You Need to Know Before You Apply
What is the purpose of this trial?
This Phase II randomized, double-blind, placebo-controlled, parallel-group study will evaluate the effects of pentadecanoic acid (C15:0) supplementation on red blood cell (RBC) health and predicted biological age in healthy adults aged 55 years and older. A total of 93 participants will be randomized to receive 200 mg of C15:0, 300 mg of C15:0, or placebo daily for approximately 12 weeks. The primary objective is to assess the effect of C15:0 on red blood cell distribution width (RDW-CV), a marker of RBC health, compared with placebo. Secondary outcomes include measures of inflammation, hematologic and iron metabolism markers, circulating C15:0 levels, biological age-related biomarkers, sleep quality, fatigue, energy, and health-related quality of life. Safety and tolerability will also be evaluated throughout the study.
Who Is on the Research Team?
Bruce Brown
Principal Investigator
ReCellience15, Inc
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 55 and older. Participants should not have serious health conditions that could interfere with the study or its results.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Pentadecanoic Acid
Trial Overview
The study tests daily supplements of pentadecanoic acid (C15:0) at two different doses versus a placebo over about 12 weeks, to see if it improves red blood cell health and slows biological aging in older adults. The design is randomized and double-blind.
How Is the Trial Designed?
3
Treatment groups
Experimental Treatment
Placebo Group
Participants receive 300 mg/day pentadecanoic acid (C15:0) administered as three active capsules daily for approximately 12 weeks.
Participants receive 200 mg/day pentadecanoic acid (C15:0) administered as three capsules daily (2 active capsules and 1 placebo capsule) for approximately 12 weeks.
Participants receive three placebo capsules daily for approximately 12 weeks. Placebo capsules are matched to the active study product in appearance and packaging.
Find a Clinic Near You
Who Is Running the Clinical Trial?
ReCellience15, Inc
Lead Sponsor
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.